NuGene International Financials
| NUGN Stock | USD 0.01 0 25.00% |
NuGene |
NuGene International Stock Summary
NuGene International competes with Aramark Holdings, SMX Public, Odyssey Marine, and Mills Music. Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 17 State Street, |
| Sector | Financial Services |
| Industry | Shell Companies |
| Benchmark | Dow Jones Industrial |
| Website | www.liventogroup.com |
| Phone | 980 432 8241 |
| Currency | USD - US Dollar |
NuGene International Key Financial Ratios
NuGene International's financial ratios allow both analysts and investors to convert raw data from NuGene International's financial statements into concise, actionable information that can be used to evaluate the performance of NuGene International over time and compare it to other companies across industries.| Return On Asset | -9.44 | |||
| Number Of Employees | 11 | |||
| Beta | 4.89 | |||
| Z Score | -89.9 |
NuGene Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuGene International's current stock value. Our valuation model uses many indicators to compare NuGene International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuGene International competition to find correlations between indicators driving NuGene International's intrinsic value. More Info.NuGene International is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value NuGene International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NuGene International's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NuGene International Systematic Risk
NuGene International's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NuGene International volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on NuGene International correlated with the market. If Beta is less than 0 NuGene International generally moves in the opposite direction as compared to the market. If NuGene International Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NuGene International is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NuGene International is generally in the same direction as the market. If Beta > 1 NuGene International moves generally in the same direction as, but more than the movement of the benchmark.
NuGene International January 9, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NuGene International help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NuGene International. We use our internally-developed statistical techniques to arrive at the intrinsic value of NuGene International based on widely used predictive technical indicators. In general, we focus on analyzing NuGene Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NuGene International's daily price indicators and compare them against related drivers.
| Downside Deviation | 23.88 | |||
| Information Ratio | 0.0241 | |||
| Maximum Drawdown | 92.86 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 28.57 |
Other Information on Investing in NuGene Pink Sheet
NuGene International financial ratios help investors to determine whether NuGene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGene with respect to the benefits of owning NuGene International security.